Objective: This study examined potential similarities and differences between women with eating disorders (EDs) in midlife and their younger counterparts.
| I N TR ODU C TI ON
Incidence of eating disorders (EDs) is commonly associated with younger women, perhaps due to the relatively early typical age of onset and the gender disparity frequently seen (e.g., Fairburn & Harrison, 2003) . However, studies of women in midlife (a commonly used range is 35-55 years, although definitions often vary) suggest that around 5% meet diagnostic criteria for an ED, with greater numbers falling within the spectrum of eating disturbance (Mangweth-Matzek et al., 2014 ; see also Larrañaga, Docet, & García-Mayor, 2012; Marcus, Bromberger, Wei, Brown, & Kravitz, 2007; McGuinness & Taylor, 2016; Slof-Op't Landt et al., 2017) . Distinct symptoms, such as binge eating and fear of weight gain, have been found to occur in >10% of midlife women (e.g., Fairweather-Schmidt, Lee, & Wade, 2015; de Freitas, Appolinario, Souza, & Sichieri, 2008; Marcus et al., 2007) and a number of studies suggest that admission rates of midlife women to ED units have increased markedly in recent decades (e.g., Ackard, Richter, Frisch, Mangham, & Cronemeyer, 2013; .
Given these concerning statistics, alongside findings that older age is associated with poorer outcome (e.g., Ackard, Richter, Egan, & Cronemeyer, 2014; Marcus et al., 2007) , it is perhaps surprising that there exists little information on the characteristics of midlife women presenting for outpatient ED treatment. Elran-Barak et al. (2015) looked at individuals seeking treatment at one of four sites in the United States, finding that prevalence of bulimia nervosa (BN) was lower in midlife individuals (age 40 years) than a younger sample (18-25 years of age), but that binge-eating disorder (BED) and atypical EDs were more common. Prevalence of anorexia nervosa (AN) did not differ between groups. This study provided important information on diagnostic prevalence, but only reported comparisons between younger and older women within diagnostic groups. Therefore, more information is needed concerning whether midlife women differ from younger groups in degree of ED pathology, for example. Elran-Barak et al. (2015) also Int J Eat Disord. 2018;51:3-9.
wileyonlinelibrary.com/journal/eat -Barak et al., 2015) , have tended to focus on more broadly-defined eating pathology (Slevec & Tiggemann, 2011) , with many concerned only with community samples or those presenting for residential treatment. Some data suggest that midlife women report fewer concerns about body shape compared to younger patients but may experience poorer quality of life, and higher levels of psychological distress and interpersonal problems (e.g., Ackard et al., 2014) . Other equivocal data concern age of onset, with some studies finding older age of onset (and longer duration of illness) in midlife samples. This contrasts with data suggesting that age of onset in some EDs is decreasing (e.g., Favaro, Caregaro, Tenconi, Bosello, & Santonastaso, 2009 ) and might suggest that there is a subgroup of older individuals who develop an ED later in life (i.e., late onset; see Bueno et al., 2014; Gupta, 1990) . Such 'late onset' EDs have been variously defined as over 40 years old or over 25 years old (Bueno et al., 2014) , reflecting the view that age of onset is notoriously "difficult to determine with any precision in most cases" (Arcelus, Mitchell, Wales, & Nielsen, 2011, p. 729) .
Given the small number of studies, it is perhaps unsurprising that some contradictions have arisen. Differences between the studies of Ackard et al. (2013) Robinson, 1993) .
The lack of information on midlife women led one group of authors to conclude recently that "our understanding of the needs of [middle-aged] women seeking treatment is in its nascence" (Ackard et al., 2013, p. 177 , 2015; . The method of dividing the sample into three separate groups was chosen in order to include the full age spectrum, whilst being able to look at differences between clearly-defined age groups that have been previously studied (cf., ElranBarak et al., 2015) . We were also interested in whether age differences existed between those who did and did not attend their initial assessment as this has important implications for accessing treatment. Given limited findings to-date, we hypothesized that BED would be more common in the midlife group. In line with others (Mangweth-Matzek et al., 2014) our clinical experience suggests that midlife women present with similar levels of symptoms and impairment to younger samples, and were interested to see whether this was substantiated in a large, treatment-seeking sample.
| M ET HOD

| Participants
Participants were referred to an outpatient eating disorders service based in the UK. This service offers specialist, evidence-based treatment to adults with an ED, including guided self-help, cognitive behavior therapy, and interpersonal psychotherapy. Some individuals referred to the service will subsequently be referred for more intensive treatment (e.g., inpatient care). Between April 2014 and April 2017, 896 outpatient referrals were received, the majority of which came from primary care (n 5 641; 74.8%). In line with the study's primary aims, for remaining analyses only those who attended for assessment were included. Men (n 5 47; 6.3%) were also excluded due to relatively small numbers. Participants were subsequently stratified by age into three groups: 18-25 years (54.3%; n 5 382), 25-40 years (28.4%, n 5 200) and 40 years and above (17.2%, n 5 121). The study was approved by the local NHS Quality and Audit Team.
| Procedures
Individuals met with a qualified clinician (e.g., nurse specialist, psycholo- suggested to predict ED case status ). Cronbach's a was .92.
The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; Barkham et al., 2001 ) is a 34-item scale, which provides a measure of general psychological distress experienced over the previous 7 days. Items are scored from 0 to 4 and provide a total score, calculated as the mean of all items multiplied by 10 (see Connell et al., 2007) . A cutoff of 10 is recommended to indicate clinical significance and its utility in the study of individuals with EDs has been established (Jenkins & Turner, 2014 ). Cronbach's a was .95.
| Statistical analyses
v 2 tests were used to examine differences among groups on categorical variables (e.g., diagnoses, assessment attendance) and continuous data (e.g., age of onset, EDE-Q scores) were analyzed with Kruskal-Wallis or Mann-Whitney procedures due to non-normal distribution of data.
Significant differences were explored using post hoc Mann-Whitney U tests. Significance level was set at p < .05 and all tests were conducted using SPSS Version 22. 
| Diagnostic differences
As summarized in Table 1 
| Previous treatment
Results found no differences between age groups regarding receipt of previous treatment (v 2 (2) 5 1.69, P 5 .431); see Table 2 .
| Markers of disordered eating
As shown in Table 2 , BMI differed across groups (H(2) 5 17.48, P < .001), with post hoc analyses finding that the youngest group (18-25 years) was lower than both other groups, which were statistically equivalent. Duration of illness differed across groups (H(2) 5 207.76, P < .001), with post hoc analyses finding that all groups differed from 
| Psychological distress and psychosocial impairment
Scores on the CORE-OM (H(2) 5 3.20, P 5 .202) and CIA (H(2) 5 2.47, p 5 .292) were equivalent across groups. Degree of distress and impairment was high within the sample, with 498 of 559 (89.1%) individuals scoring above 10 on the CORE-OM, and 501 of 560 (89.5%) scoring above 16 on the CIA.
| Age of onset
Age of onset was different across groups (H(2) 5 10.32, p 5 .006), with the youngest group (18-25 years) reporting a younger age of onset than the other two groups, which were statistically equivalent.
Of 307 individuals for whom data were available, only 2 (0.7%) were documented as having an ED onset over 40 years of age and 20 (6.5%) over the age of 25. Statistical comparisons between groups were therefore not performed. However, for those with an onset over 25, 7
(35.0%) had AN, 4 (20.0%) BN, and the remainder 'other EDs' (n 5 9;
45.0%). There were no individuals with BED with a reported onset after 25 years of age.
| D I SCUSSION
The current study aimed to describe the characteristics of women in midlife who present for treatment of EDs. Overall, slightly fewer than 20% of individuals assessed for treatment were aged over 40 and, of these, just over one-third presented with atypical or 'other' eating disorders.
Comparison with existing studies suggests that the proportion of atypical EDs is similar, at around 30-40% (see Ackard et al., 2013; Elran-Barak et al., 2015) , but proportions of other diagnoses were more variable. For example, similar numbers of BN were observed between the current study (20.7%) and that of Ackard et al. (2013) (16.7%), with slightly higher rates (29.9%) reported by Elran-Barak et al. (2015) . Regarding BED, the results presented here concur with those of Elran-Barak et al. in suggesting that women in midlife are more likely to be diagnosed with BED than younger individuals. Findings regarding AN are more equivocal, partly confounded by the fact that many studies have included inpatient samples, which are likely to report a higher proportion of individuals with AN (e.g., . However, the finding reported here that women in midlife are less likely to be diagnosed with AN has been reported previously (Ackard et al., 2014; cf. Elran-Barak et al., 2015) .
Looking at ED symptoms, results suggest that midlife women present perhaps as more similar than they are different compared to younger groups (see also Perez, Hernandez, Clarke, & Joiner, 2007) .
Although levels of ED pathology, as measured by the Global scale of the EDE-Q, were similar, the youngest group (18-25 years) reported lower weight and shape concerns than the older groups, which were equivalent, a finding similar to that of Tiggemann and Stevens (1999) in a sample of 180 women aged between 18 and 60. Similar patterns were also evident in BMI and age of onset. The finding that duration of illness is longer (e.g., Forman & Davis, 2005) was supported, suggesting that women in midlife presenting for treatment have lived with the illness for longer than their younger counterparts, which might negatively affect treatment outcome (e.g., Reas, Williamson, Martin, & Zucker, 2000) . Although this should not be taken as evidence that older women cannot benefit from treatment, it does suggest that greater efforts should be made to intervene with disordered eating at earlier stages of the illness. The finding of a longer duration of illness, however, is confounded by obvious age differences between groups. Indeed, mean duration of illness (27.4 years) of the oldest group exceeded the upper age limit for the youngest group.
Many of these findings, however, should be seen in the context of the distribution of ED diagnoses. For example, it is likely that differences in BMI, for example, were strongly related to the higher prevalence of AN in the younger sample and BED in the older samples. However, as BMI increases with age (Deurenberg, Weststrate, & Seidell, 1991) , this conclusion cannot be confirmed in the current study. Interestingly, the current study showed that all age groups were equivalent on measures of psychological distress and impairment (cf. Ackard et al., 2014) , and scores for the midlife group were in line with other studies of ED samples (e.g., Jenkins, 2013; Jenkins & Turner, 2014) , again suggestive of similarity.
Investigating age of onset within EDs was a secondary aim of the study, although this is difficult to determine accurately (Arcelus et al., 2011 ) and the procedure was not standardized in the current study.
Given these caveats, relatively small numbers of 'late onset' cases were seen, with smaller proportions than previous work (e.g., Bueno et al., 2014; Kimura, Tonoike, Muroya, Yoshida, & Ozaki, 2007) . Of particular note, there were no cases of 'late onset' BED in this large sample, although this has been documented (e.g., Beck, Casper, & Andersen, 1996) and more work is required in this area given what little is known (Bueno et al., 2014) . In addition to possibly being related to diagnostic distribution within the different age groups, findings may also reflect different referral, identification, and assessment practices across time periods. Thus, the possibility that cohort effects influenced findings represents a limitation of the study, which nonetheless provides a cross-sectional view of eating pathology and impairment across the age range.
The current study adds to the literature in a number of ways.
Firstly, it presents information from a large sample of women regarding prevalence of ED diagnoses and symptoms, showing similar figures to existing work (e.g., Ackard et al., 2014) . However, it also goes beyond this by including a large sample of women presenting for outpatient treatment and looking at both diagnostic breakdown (e.g., Elran-Barak et al., 2015) and wider symptoms. The study presents data on three distinct age groups, perhaps revealing interesting similarities amongst those aged over 25. Finally, it reviewed age of onset, although found few individuals reporting illness onset beyond 25 years of age, which warrants further research. Some shortcomings and limitations should be noted. As men were omitted from this study, this perhaps lends support to the idea that "men aged midlife and beyond might be the most stigmatized group to suffer from an eating disorder" (Reas & Stedal, 2015, p. 254) . The study was limited by use of retrospective review of routinely-referred patients within an outpatient setting in the UK, particularly as results may differ across settings (e.g., inpatients, or primary care). As sociocultural factors have been associated with presentation of different EDs (e.g., Hoek et al., 1995) , further studies might seek to replicate the findings reported here. In addition, a large proportion of individuals indicated that they had previously received treatment for an ED, although this proportion is similar to other tertiary centers in the UK (e.g., Treasure et al., 1996) and clinics in the US (e.g., Crow, Mussell, Peterson, Knopke, & Mitchell, 1999) . Differences with previous work might reflect this methodological aspect but could also be related to the diagnostic criteria used (i.e., DSM-IV vs. DSM-5).
Results of the study argue for continued attention to reducing barriers to accessing treatment and identifying cases as early as possible (e.g., Reas et al., 2000) . A recent study highlighted the importance of adequate healthcare provision with regards to women in midlife (Micali et al., 2017) , and thus the present findings serve as a continued reminder that EDs occur across the age range. Further studies might look at whether EDs in older individuals are being correctly identified, and whether current psychological therapies are sufficiently personalized to address the needs of all those presenting for ED treatment.
Given the similarities across groups noted here, it likely that many core strategies will remain relevant and effective for women in midlife, but age-related differences may warrant consideration.
In summary, this study suggests that midlife women are more similar than different to their younger counterparts, although older women appear more likely to present with BED. Degree of global eating pathology, ED-related psychosocial impairment, and psychological distress remained similar across the age range. Further work in this area is needed, particularly concerning age of onset and inclusion of male samples.
